Uncategorized
Steroid implant reduces macular thickness with small vision gain
SAN FRANCISCO — Long-term anatomic outcomes improved but with limited visual improvement in phakic eyes treated for posterior uveitis with repeated dexamethasone intravitreal injections, according to a scientific poster presented here. Dorukcan Akincioglu, MD, and colleagues assessed outcomes in eyes with noninfectious posterior uveitis with cystoid macular edema treated with the dexamethasone 0.7 mg sustained release intravitreal implant Ozurdex (Allergan) over 20 months.